{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:49:59Z","timestamp":1788922199481,"version":"build-2803163510"},"reference-count":21,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,5,23]]},"DOI":"10.1248\/bpb.b24-00832","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T22:07:39Z","timestamp":1747951659000},"page":"682-686","source":"Crossref","is-referenced-by-count":1,"title":["Antidepressant-Like Effects of Intracerebroventricular Injection of Nociceptin Analogs in Mice"],"prefix":"10.1248","volume":"48","author":[{"given":"Osamu","family":"Nakagawasai","sequence":"first","affiliation":[{"name":"Division of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4\u20134\u20131 Komatsushima, Aoba-ku, Sendai 981\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4\u20134\u20131 Komatsushima, Aoba-ku, Sendai 981\u20138558, Japan"},{"name":"Department of Pharmacology, School of Pharmacy, International University of Health and Welfare, 2600\u20131 Kitakanemaru, Ohtawara, Tochigi 324\u20138501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futa","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4\u20134\u20131 Komatsushima, Aoba-ku, Sendai 981\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Ambo","sequence":"additional","affiliation":[{"name":"Division of Biochemistry, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4\u20134\u20131 Komatsushima, Aoba-ku, Sendai 981\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Abe","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4\u20134\u20131 Komatsushima, Aoba-ku, Sendai 981\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Nemoto","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4\u20134\u20131 Komatsushima, Aoba-ku, Sendai 981\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Tan-No","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4\u20134\u20131 Komatsushima, Aoba-ku, Sendai 981\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Gavioli EC, Calo G. Nociceptin\/orphanin FQ receptor antagonists as innovative antidepressant drugs. <i>Pharmacol. Ther.<\/i>, <b>140<\/b>, 10\u201325 (2013).","DOI":"10.1016\/j.pharmthera.2013.05.008"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, Caput D, Vassart G, Meunier JC. ORL1, a novel member of the opioid receptor family: cloning, functional expression and localization. <i>FEBS Lett.<\/i>, <b>341<\/b>, 33\u201338 (1994).","DOI":"10.1016\/0014-5793(94)80235-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Neal CR Jr, Mansour A, Reinscheid R, Nothacker HP, Civelli O, Akil H, Watson SJ Jr. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. <i>J. Comp. Neurol.<\/i>, <b>412<\/b>, 563\u2013605 (1999).","DOI":"10.1002\/(SICI)1096-9861(19991004)412:4<563::AID-CNE2>3.0.CO;2-Z"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ubaldi M, Cannella N, Borruto AM, Petrella M, Micioni Di Bonaventura MV, Soverchia L, Stopponi S, Weiss F, Cifani C, Ciccocioppo R. Role of nociceptin\/orphanin FQ-NOP receptor system in the regulation of stress-related disorders. <i>Int. J. Mol. Sci.<\/i>, <b>22<\/b>, 12956 (2021).","DOI":"10.3390\/ijms222312956"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Armstead WM. Nociceptin\/orphanin phenylalanine glutamine (FQ) receptor and cardiovascular disease. <i>Cardiovasc. Ther.<\/i>, <b>29<\/b>, 23\u201328 (2011).","DOI":"10.1111\/j.1755-5922.2010.00241.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Lambert DG. The nociceptin\/orphanin FQ receptor: a target with broad therapeutic potential. <i>Nat. Rev. Drug Discov.<\/i>, <b>7<\/b>, 694\u2013710 (2008).","DOI":"10.1038\/nrd2572"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Gavioli EC, Rom\u00e3o PR. NOP receptor ligands as potential agents for inflammatory and autoimmune diseases. <i>J. Amino Acids<\/i>, <b>2011<\/b>, 836569 (2011).","DOI":"10.4061\/2011\/836569"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Holanda VAD, de Almeida RN, de Oliveira MC, da Silva Junior ED, Galv\u00e3o-Coelho NL, Calo G, Ruzza C, Gavioli EC. Activation of NOP receptor increases vulnerability to stress: role of glucocorticoids and CRF signaling. <i>Psychopharmacology<\/i> (Berl.), <b>241<\/b>, 1001\u20131010 (2024).","DOI":"10.1007\/s00213-024-06533-9"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Nakagawasai O, Ambo A, Takahashi K, Onogi H, Nishimura Y, Okubo M, Nemoto W, Tan-No K. Intracerebroventricular administration of dermorphin-dynorphin analogs producing antidepressant-like effects through activation of <i>\u03bc<\/i><sub>1<\/sub>- and <i>\u03ba<\/i>-opioid receptors in mice. <i>Biol. Pharm. Bull.<\/i>, <b>45<\/b>, 1203\u20131207 (2022).","DOI":"10.1248\/bpb.b22-00164"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Nakagawasai O, Takahashi K, Ambo A, Onuma K, Takahashi N, Nemoto W, Tan-No K. Antidepressant effect of intracerebroventricularly administered deltorphin analogs in the mouse tail suspension test. <i>Biol. Pharm. Bull.<\/i>, <b>45<\/b>, 538\u2013541 (2022).","DOI":"10.1248\/bpb.b21-01078"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Ellert-Miklaszewska A, Poleszak K, Kaminska B. Short peptides interfering with signaling pathways as new therapeutic tools for cancer treatment. <i>Future Med. Chem.<\/i>, <b>9<\/b>, 199\u2013221 (2017).","DOI":"10.4155\/fmc-2016-0189"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Xiao YF, Jie MM, Li BS, Hu CJ, Xie R, Tang B, Yang SM. Peptide-based treatment: a promising cancer therapy. <i>J. Immunol. Res.<\/i>, <b>2015<\/b>, 761820 (2015).","DOI":"10.1155\/2015\/761820"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Kawano M, Okada K, Honda T, Nose T, Sakaguchi K, Costa T, Shimohigashi Y. Structural requirements of nociceptin antagonist Ac-RYYRIK-NH<sub>2<\/sub> for receptor binding. <i>J. Pept. Sci.<\/i>, <b>8<\/b>, 561\u2013569 (2002).","DOI":"10.1002\/psc.415"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Ambo A, Kohara H, Kawano S, Sasaki Y. Opioid receptor-like 1 (ORL1) receptor binding and the biological properties of Ac-Arg-Tyr-Tyr-Arg-Ile-Arg-NH<sub>2<\/sub> and its analogs. <i>J. Pept. Sci.<\/i>, <b>13<\/b>, 672\u2013678 (2007).","DOI":"10.1002\/psc.900"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Haley TJ, McCormick WG. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. <i>Br. J. Pharmacol. Chemother.<\/i>, <b>12<\/b>, 12\u201315 (1957).","DOI":"10.1111\/j.1476-5381.1957.tb01354.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Onogi H, Nakagawasai O, Sato A, Mitazaki S, Nakaya K, Watanabe K, Niijima-Yaoita F, Tan-No K, Arai Y, Kikuchi T, Tadano T. <i>p<\/i>-Hydroxyamphetamine causes prepulse inhibition disruption in mice: contribution of serotonin neurotransmission. <i>Behav. Brain Res.<\/i>, <b>224<\/b>, 159\u2013165 (2011).","DOI":"10.1016\/j.bbr.2011.06.002"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Z\u00e1dori ZS, Shujaa N, K\u00f6les L, Kir\u00e1ly KP, Tekes K, Gyires K. Nocistatin and nociceptin given centrally induce opioid-mediated gastric mucosal protection. <i>Peptides<\/i>, <b>29<\/b>, 2257\u20132265 (2008).","DOI":"10.1016\/j.peptides.2008.09.012"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Hughes J, Kosterlitz HW, Leslie FM. Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics. <i>Br. J. Pharmacol.<\/i>, <b>53<\/b>, 371\u2013381 (1975).","DOI":"10.1111\/j.1476-5381.1975.tb07373.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Redrobe JP, Calo G, Regoli D, Quirion R. Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test. <i>Naunyn Schmiedebergs Arch. Pharmacol.<\/i>, <b>365<\/b>, 164\u2013167 (2002).","DOI":"10.1007\/s00210-001-0511-0"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Park JY, Chae S, Kim CS, Kim YJ, Yi HJ, Han E, Joo Y, Hong S, Yun JW, Kim H, Shin KH. Role of nociceptin\/orphanin FQ and nociceptin opioid peptide receptor in depression and antidepressant effects of nociceptin opioid peptide receptor antagonists. <i>Korean J. Physiol. Pharmacol.<\/i>, <b>23<\/b>, 427\u2013448 (2019).","DOI":"10.4196\/kjpp.2019.23.6.427"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Kawahara Y, Hesselink MB, van Scharrenburg G, Westerink BH. Tonic inhibition by orphanin FQ\/nociceptin of noradrenaline neurotransmission in the amygdala. <i>Eur. J. Pharmacol.<\/i>, <b>485<\/b>, 197\u2013200 (2004).","DOI":"10.1016\/j.ejphar.2003.11.061"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/5\/48_b24-00832\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T04:09:06Z","timestamp":1748059746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/5\/48_b24-00832\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b24-00832","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"article-number":"b24-00832"}}